F1000Research · 2020 · 56 citations · 18 references
Veterinary MedicineImmunologyInfectious DiseasesMolecular VirologyVaccinologyVirologyClinical Development Of VaccinesVaccinationVaccine DevelopmentVaccine PlatformsVaccines For Emerging PathogensViral VaccinesCoronavirus VaccinesSars-cov-2 InfectionTherapeutic Vaccine Development
COVID-19 emerged in late 2019 and has rapidly spread through many countries globally. The causative SARS-CoV-2 virus was not known until recently, and there is little or no natural immunity in human populations. There is an urgent need for vaccines and drugs to combat this new pandemic. In just a few months, huge efforts and resources by government, academia, and industry have been thrown into the race to develop a vaccine. This brief review summarizes and discusses the array of technologies being applied to vaccine development, highlighting the strengths and weaknesses of the various approaches.
18
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael et al. · New England Journal of Medicine · 2020 · 3.5K citations · Full text
Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan et al. · The Lancet · 2020 · 1.5K citations · Full text
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen, Teresa Lambe, Alexandra J. Spencer et al. · Nature · 2020 · 990 citations · Full text
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi, Michael J. Hogan, Rebecca S. Pelc et al. · Nature · 2017 · 888 citations · Full text
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Yushun Wan, Jian Shang, Shihui Sun et al. · Journal of Virology · 2019 · 703 citations · Full text